Every specialty pharmacy in your network collects patient consent. Almost none of them collect it the same way. Different forms, different scopes, different retention practices, different interpretations of what the patient actually authorized. That gap is where your compliance risk lives, and it’s invisible until an auditor, a regulator, or a plaintiff’s attorney goes looking for it.
Here’s what most buyers discover when they go shopping for a fix: the tools marketed as “consent management” were built for entirely different problems. Cookie banners. Marketing preference centers. Clinical trial eConsent. Data-licensing governance. All real categories. None of them was built to verify, reconcile, and monitor patient consent across a network of specialty pharmacies, hubs, and channel partners.
Consent Clearinghouse™ from Claritas Rx is the first dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma. This guide explains what network-level consent management actually requires, where the commonly considered alternatives fit, and why they solve different problems.
Quick guide: Consent Clearinghouse™ and The Status Quo
- Consent Clearinghouse™ (Claritas Rx): The first and only solution for verifying, reconciling, and continuously monitoring patient consent across every SP, hub, and data partner in your network
- The status quo: Letting each SP and hub manage consent its own way. It’s the default most manufacturers are living with, and the riskiest option on this list
What does network-level consent management actually require?
- Verification across sources: Confirm that valid, in-scope consent exists for every patient record flowing into your data ecosystem, rather than assuming it because a partner contract says so.
- Reconciliation across partners: Resolve the conflicts that fragmented collection creates. When one SP captured broad consent, another captured narrow consent, and the hub captured something else for the same patient, the system must determine what you’re actually authorized to do.
- Continuous monitoring: Consent isn’t a checkbox captured once. Patients revoke, authorizations expire, scopes change. A point-in-time capture tool can’t tell you that a consent you relied on last quarter is no longer valid today.
- A defensible compliance record: When a regulator or auditor asks “show me the consent behind this data use,” the answer must be a complete, centralized, auditable record, not a scramble across a dozen partner systems.
- Built for the specialty network: The solution must understand SP and hub workflows, oncology and rare disease program structures, and the data flows specific to specialty biopharma, not treat them as an edge case of web privacy.
Measured against this definition, only one solution was built for the job. Here’s the full breakdown.
Consent Clearinghouse™: The first dedicated consent solution for specialty biopharma networks
Consent Clearinghouse™ is the first dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma. It verifies, reconciles, and continuously monitors patient consent across every connected data source and network partner, giving manufacturers real-time visibility and a defensible compliance record, all in one place.
The core insight behind Consent Clearinghouse™ is that the consent problem in specialty pharma isn’t a capture problem. It’s a fragmentation problem. Your network partners are already collecting consent. The risk lives in the inconsistency: different forms, different scopes, different standards, no central reconciliation. Consent Clearinghouse™ is built to close exactly that gap.
Because it’s built by Claritas Rx, Consent Clearinghouse™ sits natively on the same data infrastructure that already connects your SPs, hubs, and channel partners: the same network integration and PHI matching foundation that powers the Ascend Platform. Consent status isn’t a separate silo; it’s connected to the patient journey itself.
Consent Clearinghouse™ capabilities
- Consent verification: Confirms valid, in-scope consent for every patient record across every connected data source
- Cross-partner reconciliation: Resolves conflicting or inconsistent consent captured by different SPs, hubs, and partners for the same patient
- Continuous monitoring: Tracks revocations, expirations, and scope changes in real time, not at the next audit
- Centralized compliance record: One defensible, auditable source of truth for every consent across the network
- Real-time manufacturer visibility: See consent status across your entire network in one place, as it changes
- Built for specialty: Designed for oncology, cell and gene therapy, and rare disease program structures from day one
Who Consent Clearinghouse™ is for:
Consent Clearinghouse™ is built for biopharma manufacturers running specialty and rare disease brands through networks of SPs, hubs, and data partners. If your consent challenge is a single website or a marketing email list, you don’t need it. If your consent challenge is a network, you have no other option that was built for it.
Bottom line: Secure consent. Confident action. If patient data flows into your organization from a partner network, this is the only solution designed to make every record in that flow defensible.
The status quo: Letting every partner do it their own way
The most common “solution” isn’t a product at all. It’s the default: each SP uses its own consent form, each hub its own authorization language, each partner its own retention and revocation process, and the manufacturer trusts that it all adds up to compliance.
It doesn’t, and the structure of the problem explains why. Consent captured inconsistently can’t be verified centrally. Conflicts between partners’ captures are never surfaced, let alone resolved. Revocations reach one system and not the others. And when the audit comes, the “record” is a months-long reconstruction project across partner organizations that have no obligation to make it easy.
Where the status quo falls short
- No verification: data flows on the assumption of consent, not the evidence of it
- No reconciliation: conflicting scopes across partners go undetected until they become findings
- No monitoring: revocations and expirations surface late or never
- No defensible record: the audit response is a scramble, not a report
Bottom line: The status quo isn’t neutral. Every quarter without centralized consent verification is accumulating risk you can’t see and didn’t choose.
Comparison: Why only one solution checks every box
The pattern repeats from category to category: each alternative governs one consent surface (research data, websites, communications, tracking pixels) while Consent Clearinghouse™ is the only solution built for the surface where specialty manufacturers carry the most exposure: the partner network itself.
The real decision isn’t “which consent tool” but “which consent problem”
If patient-level data flows into your organization from specialty pharmacies, hubs, and channel partners (and for every specialty and rare disease manufacturer, it does), none of the alternative tools address your largest consent exposure. The gap isn’t a missing capture point. It’s the absence of verification, reconciliation, and monitoring across capture points you don’t control.
That’s the gap Consent Clearinghouse™ was created to close, and as the first dedicated solution in the category, it’s currently the only thing that closes it.
Why Consent Clearinghouse™ is the only real choice for specialty network consent
Consent Clearinghouse™ stands alone because it’s the first and only solution built to standardize and centralize patient consent across the specialty biopharma network. Privacy platforms, preference managers, and data-governance tools weren’t designed for the fragmented reality of SP and hub consent collection. Consent Clearinghouse™ was, and it’s the only solution on this list that was.
Built on the Claritas Rx data infrastructure that already connects specialty networks, Consent Clearinghouse™ delivers what compliance, legal, and commercial teams actually need: verification of every consent, reconciliation of every conflict, continuous monitoring of every change, and one defensible record when it matters most.
Secure consent. Confident action. Request a demo to see how Consent Clearinghouse™ can turn your network’s biggest invisible risk into a managed, auditable asset.
| Capability | Consent Clearinghouse™ | Status Quo |
|---|---|---|
| Verifies consent across SP/hub data sources | ✓ | X |
| Reconciles conflicting consent across partners | ✓ | X |
| Continuous monitoring (revocations, expirations) | ✓ | X |
| Centralized defensible compliance record | ✓ | X |
| Built for oncology, rare disease & specialty | ✓ | X |
| Native to SP/hub network data infrastructure | ✓ | X |
| Real-time manufacturer visability | ✓ | X |
FAQs about patient consent management for specialty biopharma
A consent clearinghouse centralizes, verifies, and reconciles patient consent collected across multiple independent sources. In specialty biopharma, that means SPs, hubs, and channel partners. Rather than capturing consent at one touchpoint, it creates a single authoritative view of what each patient actually authorized, across every partner. Consent Clearinghouse™ from Claritas Rx is the first dedicated solution in this category.
Consent management platforms (CMPs) were built for websites: cookie banners, tracking preferences, digital opt-ins. A consent clearinghouse operates on a different layer entirely: the patient-level authorizations captured by your network partners that govern how patient data can flow to and be used by the manufacturer. A CMP can’t see that layer; Consent Clearinghouse™ was built for it.
When every SP and hub collects consent its own way, manufacturers receive patient data without a verified, consistent basis for using it. Conflicting scopes go undetected, revocations don’t propagate, and there’s no centralized record to produce when regulators or auditors ask. The risk isn’t that consent wasn’t collected; it’s that no one can prove what was collected, for whom, and whether it’s still valid.
No, and that’s the point. Your partners keep collecting consent within their workflows. Consent Clearinghouse™ standardizes, verifies, and reconciles what they collect, then continuously monitors it, so the manufacturer gets a unified, defensible view without re-engineering every partner’s intake process.
Consent Clearinghouse™ is built by Claritas Rx on the same data infrastructure that powers the Ascend Platform: the integrations and PHI matching foundation already connecting SPs, hubs, and partners for specialty brands. Consent status lives alongside the patient journey data it governs, rather than in a disconnected silo.
Consent Clearinghouse™ continuously monitors consent status across every connected source, so revocations, expirations, and scope changes are surfaced in real time, giving your team the visibility to act before a lapsed consent becomes a compliance finding.
